« Previous
Next »
International Journal of Obstetric Anesthesia
Volume 19, Issue 3
, Pages 254-260
, July 2010
The influence of ATP-binding cassette sub-family B member -1 (ABCB1) genetic polymorphisms on acute and chronic pain after intrathecal morphine for caesarean section: a prospective cohort study
References
- . Genetic variability and clinical efficacy of morphine. Acta Anaesthesiol Scand. 2005;49:902–908
- . Opiate induced analgesia is increased and prolonged in mice lacking p-glycoprotein. Anesthesiology. 2000;92:1392–1399
- . Genetic variants of the P-glycoprotein gene Abcb1 modulate opioid induced hyepralgesia, tolerance and dependence. Pharmacogenet Genomics. 2006;16:825–835
- . Incidence and risk factors for chronic pain after caesarean section under spinal anaesthesia. Anaesth Intensive Care. 2009;37:748–752
- . Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain. Mol Pain. 2009;5:32
- . Chronic pain following Caesarean section. Acta Anaesthesiol Scand. 2004;48:111–116
- ACBC1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients. Pharmacogenomics. 2006;7:551–561
- . Pharmacogenetics of opioids. Clin Pharmacol Ther. 2007;81:429–444
- . A synonymous polymorphism in a common MRD1 (ABCB1) haplotype shapes protein function. Biochim Biophys Acta. 2009;1794:860–871
- Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene. Pharmacogenomics. 2007;8:29–39
- Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther. 2001;297:1137–1143
- . Effect of genetic factors on opioid action. Curr Opin Anaesthesiol. 2009;22:476–482
- Environmental and genetic factors associated with morphine response in the postoperative period. Clin Pharmacol Ther. 2006;79:316–324
- . Associations of ABCB1/MDR and OPRM1 gene polymorphisms with morphine pain relief. Clin Pharmacol Ther. 2008;83:559–566
- Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers. Pharmacogenet Genomics. 2009;19:429–436
- . Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain. 2008;7:43–48
- . Short term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain. 2003;106:49–57
PII: S0959-289X(10)00027-0
doi: 10.1016/j.ijoa.2010.03.001
© 2010 Elsevier Ltd. All rights reserved.
« Previous
Next »
International Journal of Obstetric Anesthesia
Volume 19, Issue 3
, Pages 254-260
, July 2010
